BUZZ-Top of the Street: Orsted, Centrica, Societe Generale, BESI

Reuters
05-09
BUZZ-Top of the Street: Orsted, Centrica, <a href="https://laohu8.com/S/SCGLF">Societe Generale</a>, BESI

A round-up of notable broker activity this morning from Europe's top-ranked* analysts:

** Berenberg cuts Swiss specialty nylon manufacturer EMS Chemie EMSN.S to "sell" from "hold" as it sees risk of a guidance cut during H1 results due to slowing business momentum

** Citigroup downgrades Denmark's Orsted ORSTED.CO to "sell" from "neutral" citing concerns about wind power developer selling operating cashflows to fund U.S. projects and cancelling value-creating projects such as Hornsea 4

** RBC also cuts Danish medical equipment maker Coloplast COLOb.CO to "sector perform" from "outperform" citing uncertainty on CEO and strategy

** Kepler Cheuvreux downgrades British energy supplier Centrica CNA.L to "hold" from "buy" seeing no new positive catalysts post-AGM after strong performance

** UBS cuts Societe Generale SOGN.PA to "neutral" from "buy" as it sees the French bank's valuation as fair in the near term with an uncertain macro and political environment

** It also downgrades Wolters Kluwer WLSNc.AS to "neutral" from "buy" expecting organic growth to decelerate to 5% in 2026

** UBS also cuts Belgian real estate investment trust Cofinimmo COFB.BR to "neutral" from "buy" to reflect all-share offer by Aedifica AOO.BR

INITIATIONS AND REINSTATEMENTS

** J.P.Morgan starts Dutch BE Semiconductor Industries (BESI) BESI.AS with an "overweight" rating citing "substantial" revenue growth potential for the supplier of advanced packaging tools for chipmakers

** Jefferies resumes coverage of Playtech PTEC.L with "buy" rating as British gambling technology firm completed sale of Snaitech and will now return 1.8 billion euros to shareholders via a special dividend

(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)

(Reporting by Tiago Brandão and Marta Frackowiak)

((tiago.Brandao@thomsonreuters.com; marta.frackowiak@thomsonreuters.com))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10